Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
Aprogen Biologics, Inc. specializes in the production and distribution of pharmaceutical goods. The company's activities are structured across two main segments: Pharmaceutical and Bio. Its Pharmaceutical division supplies synthetic medicines, encompassing treatments for the circulatory, central nervous, and digestive systems, alongside antibiotics. Concurrently, the Bio division is dedicated to developing and manufacturing biopharmaceuticals. Aprogen Biologics was established on December 3, 1960, and its corporate headquarters are situated in Seoul, South Korea.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers.